3 transcripts
PAYS
Earnings call transcript
NASDAQ
2024 Q2
31 Jul 24
and pharmaceutical claims with a corresponding offset under current liabilities. As we did not complete any share repurchases during the second quarter, $3.9
PAYS
Earnings call transcript
NASDAQ
2024 Q1
7 May 24
and pharmaceutical claims with the corresponding offset under current liabilities.
As we did not complete any share repurchases during the first quarter, $3.9
PAYS
Earnings call transcript
NASDAQ
2023 Q4
26 Mar 24
million, reflecting the seasonal impact of tax refunds on our plasma business, offset with a strong start to the year with our patient affordability
- Prev
- 1
- Next